Alto Neuroscience (Alto Neuroscience) Other Long Term Assets : $0.06 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Other Long Term Assets?

Alto Neuroscience's other long-term assets for the quarter that ended in Mar. 2024 was $0.06 Mil.

Alto Neuroscience's quarterly other long-term assets declined from Sep. 2023 ($0.20 Mil) to Dec. 2023 ($0.13 Mil) but then stayed the same from Dec. 2023 ($0.13 Mil) to Mar. 2024 ($0.06 Mil).

Alto Neuroscience's annual other long-term assets increased from Dec. 2021 ($0.05 Mil) to Dec. 2022 ($0.46 Mil) but then declined from Dec. 2022 ($0.46 Mil) to Dec. 2023 ($0.13 Mil).

Alto Neuroscience Other Long Term Assets Historical Data

The historical data trend for Alto Neuroscience's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Other Long Term Assets Chart

Alto Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Other Long Term Assets

0.05

0.46

0.13

Alto Neuroscience Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial			0.46	-	0.20	0.13	0.06

Alto Neuroscience Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024